Glenmark Pharmaceuticals Ltd Net Profit is INR 233.99 crores in Q3 FY 2020-2021

Glenmark Pharmaceuticals Ltd Q3 FY20-21 Quarter Result

Glenmark Pharmaceuticals Ltd Net Profit is INR 233.99 crores in Quarter 3, October – December of Financial Year 2020-2021.

Quarterly Net Earnings Year-on-Year

Glenmark Pharmaceuticals Ltd Quarter Net Profit is Down by -8 % from Last Year Quarter and Net Profit of INR 233.99 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Profit was INR 255.54 crores.

Quarterly Net Sales Year-on-Year

Glenmark Pharmaceuticals Ltd Quarter Sale is up 5 % from Last Quarter. Sales of 2952.48 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 2815.04

Annual Sales & Net Earning

Glenmark Pharmaceuticals Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 9865.47 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 924.99 crores.


Glenmark Pharmaceuticals Ltd Stock Information

SectorPharmaceuticals
IndustryPharmaceuticals – Indian – Bulk Drugs & Formln
AboutGlenmark Pharmaceuticals is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).
Latest Qaurter EPS8.292570988674152

Glenmark Pharmaceuticals Ltd Stock Analysis:

Get more Quarterly Earnings Results of companies

Get complete data on Glenmark Pharmaceuticals Ltd

Leave a Comment

Your email address will not be published. Required fields are marked *